Why can primary angioplastics be ineffective despite the precocity of the intervention?
Giuseppe PattiChiara GhiglienoPublished in: European heart journal supplements : journal of the European Society of Cardiology (2022)
Early coronary revascularization is a first choice therapeutic strategy in the case of acute myocardial infarction (MI). Despite an early coronary angioplasty, however, in some cases, there is a lower efficacy of revascularization, with less favourable clinical outcome in the short and long terms. Various elements participate in the distant prognosis after primary coronary angioplasty (PCI). Among the clinical risk factors that predispose to a recurrence of ischaemic cardiovascular events are advanced age, diabetes mellitus, chronic renal failure, peripheral vascular disease, atrial fibrillation and the multiplicity of cardiovascular risk factors, which identify a higher baseline risk profile. The risk factors associated with the percutaneous interventional procedure include the presence of diffuse or complex coronary lesions, the use of small diameter stents or a suboptimal post procedural thrombolysis in MI flow. The occurrence of procedural complications, such as no-reflow, is in fact associated with an increase in the infarct area and a worse prognosis, as it favours negative ventricular remodelling. The presence of concomitant right ventricular dysfunction, the high ventricular arrhythmic burden in the acute phase, the presence of risk factors for thrombosis or intra-stent restenosis also affect the outcome after primary PCI.
Keyphrases
- coronary artery disease
- percutaneous coronary intervention
- acute myocardial infarction
- cardiovascular events
- coronary artery bypass grafting
- st segment elevation myocardial infarction
- risk factors
- cardiovascular risk factors
- st elevation myocardial infarction
- coronary artery
- antiplatelet therapy
- atrial fibrillation
- left ventricular
- heart failure
- catheter ablation
- pulmonary embolism
- acute coronary syndrome
- randomized controlled trial
- aortic stenosis
- cardiovascular disease
- minimally invasive
- coronary artery bypass
- type diabetes
- lymph node
- metabolic syndrome
- risk assessment
- left atrial
- oxidative stress
- low grade
- acute ischemic stroke
- adipose tissue
- mitral valve
- venous thromboembolism
- insulin resistance
- aortic valve
- drug induced